World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
15500
World Ranking
8677
National Ranking
3893

Overview

Jerry M. Collins is affiliated with the National Institutes of Health in the United States. Their research focuses primarily on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with particular specialization in Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Genetics, and Computational Theory and Mathematics.

The scientist's work addresses multiple topics in cancer research including HER2/EGFR in Cancer Research, Computational Drug Discovery Methods, Cancer therapeutics and mechanisms, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Epigenetics and DNA Methylation, and Lung Cancer Treatments and Mutations.

Key recent publications by Jerry M. Collins include:

  • Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource (2023), Molecular Cancer Therapeutics
  • Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas (2020), Oncotarget
  • F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd (2021), Molecular Cancer Therapeutics
  • Phase 1 study of Z-Endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors (2021), Oncotarget
  • Abstract PD7-06: A randomized phase II trial of tamoxifen versus Z-endoxifen HCL in postmenopausal women with metastatic estrogen receptor positive, HER2 negative breast cancer (2020), Cancer Research

Jerry M. Collins has frequently published in venues such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • Molecular Cancer Therapeutics
  • Oncotarget
  • Clinical Cancer Research

Frequent collaborators in their research include James H. Doroshow, Geraldine O'Sullivan Coyne, Shivaani Kummar, Richard Piekarz, and Larry Rubinstein. These coauthors have partnered with Collins across multiple projects and publications.

Best Publications

  • ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  • Accelerated Titration Designs for Phase I Clinical Trials in Oncology

    Richard Simon;Boris Freidlin;Larry Rubinstein;Susan G. Arbuck

  • PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

    Robert Yarchoan;Rose V. Thomas;Jean Pierre Allain;Nanette Mcatee

  • Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.

    Raymond W Klecker;Jerry M Collins;Robert Yarchoan;Rose Thomas

  • Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

    Carl C. Peck;William H. Barr;Leslie Z. Benet;Jerry Collins

  • Cancer Chemotherapy: Principles and Practice

    Bruce Chabner;Jerry M. Collins

  • Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

    Shivaani Kummar;Robert Kinders;Martin E. Gutierrez;Larry Rubinstein

  • Plasma Pharmacokinetics of Adriamycin and Adriamycinol: Implications for the Design of in Vitro Experiments and Treatment Protocols

    Raymond F. Greene;Jerry M. Collins;Jean F. Jenkins;James L. Speyer

  • Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines

    Susan L. Holbeck;Jerry M. Collins;James H. Doroshow

  • Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered

    Solomon Zimm;Jerry M. Collins;Riccardo Riccardi;Dondra O'Neill

  • Phase I and Pharmacological Studies of 5-Fluorouracil Administered Intraperitoneally

    James L. Speyer;Jerry M. Collins;Robert L. Dedrick;Murray F. Brennan

  • Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

    Anthony Elias;Louise Ryan;Aaron Sulkes;Jerry Collins

  • Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.

    Michael E. Fitzsimmons;Jerry M. Collins

  • Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors

    Khanh Do;Deborah Wilsker;Jiuping Ji;Jennifer Zlott

  • The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

    Susan L. Holbeck;Richard Camalier;James A Crowell;Jeevan Prasaad Govindharajulu

  • Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements

    Shivanni Kummar;Helen X. Chen;John Wright;Susan Holbeck

  • Portal Levels and Hepatic Clearance of 5-Fluorouracil after Intraperitoneal Administration in Humans

    James L. Speyer;Paul H. Sugarbaker;Jerry M. Collins;Robert L. Dedrick

  • Potential roles for preclinical pharmacology in phase I clinical trials.

    J M Collins;D S Zaharko;R L Dedrick;B A Chabner

  • Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug Development

    Jerry M. Collins;Charles K. Grieshaber;Bruce A. Chabner

  • Chemosensitivity Testing of Human Colorectal Carcinoma Cell Lines Using a Tetrazolium-based Colorimetric Assay

    Jae-Gahb Park;Barnett S. Kramer;Seth M. Steinberg;James Carmichael

Frequent Co-Authors

James H. Doroshow
James H. Doroshow National Institutes of Health
Timothy J. Kinsella
Timothy J. Kinsella Brown University
Charles E. Myers
Charles E. Myers University of Virginia
David G. Poplack
David G. Poplack Baylor College of Medicine
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Otto Muzik
Otto Muzik Wayne State University
Bruce A. Chabner
Bruce A. Chabner Harvard University
Robert H. Wiltrout
Robert H. Wiltrout National Institutes of Health
Leslie Z. Benet
Leslie Z. Benet University of California, San Francisco
Samuel Broder
Samuel Broder Precision BioSciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open the door to a diverse array of careers in healthcare, diagnostics, and nutrition. Today, many students are choosing flexible online programs to advance their education and job prospects in these fields.

For those drawn to data, managing health records is a vital part of modern medicine. Earning a him degree online prepares graduates for in-demand roles in hospitals and clinics. If nutrition and wellness are your passion, consider enrolling in the cheapest online nutrition degree programs to gain specialized knowledge and skills.

Diagnostic careers are also popular among Biology and Biochemistry graduates. High-quality online sonography programs teach students how to use medical imaging to support patient care. If radiologic technology interests you, finding the cheapest radiology tech programs can help you enter the workforce quickly and affordably.

Exploring these online degree pathways can complement or expand your expertise in Biology and Biochemistry and help you build a rewarding healthcare career.

Best Scientists Citing Jerry M. Collins

Trending Scientists

Recently Published Articles